CapsCanada, a leading provider of capsules for pharmaceutical drugs and dietary supplements, announced the addition of a new, state-of-the-art, dedicated hydroxypropyl methylcellulose (HPMC) capsule manufacturing facility. 

With this investment, CapsCanada has now increased capsule output by 50%. Produced with 100% plant-derived material, CapsCanada’s K-CAPS® are ideal for consumers with dietary restrictions prohibiting the consumption of animal byproduct and are suitable for a wide range of formulations.

“The new factory was built because we saw worldwide acceptance of K-CAPS® as the preferred HPMC based capsule. Compared to other HPMC capsules, K-CAPS® have exceptional aesthetics and perform better on automatic capsule filling machines; directly translating into reduced raw material loss and downtime for our customers.” According to Jonathan Gilinski, executive director.

The company previously made a $10 million expansion of their Windsor, Ontario site in 2014, experiencing growing global demand for its products. K-CAPS® are already sold in more than 60 countries worldwide.